NO178620C - Isatinoksimderivater, farmasöytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for fremstilling av medikamenter - Google Patents

Isatinoksimderivater, farmasöytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for fremstilling av medikamenter

Info

Publication number
NO178620C
NO178620C NO922686A NO922686A NO178620C NO 178620 C NO178620 C NO 178620C NO 922686 A NO922686 A NO 922686A NO 922686 A NO922686 A NO 922686A NO 178620 C NO178620 C NO 178620C
Authority
NO
Norway
Prior art keywords
compounds
medicaments
manufacture
pharmaceutical compositions
oxime derivatives
Prior art date
Application number
NO922686A
Other languages
English (en)
Other versions
NO922686L (no
NO178620B (no
NO922686D0 (no
Inventor
Frank Watjen
Joergen Drejer
Leif Helth Jensen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of NO922686D0 publication Critical patent/NO922686D0/no
Publication of NO922686L publication Critical patent/NO922686L/no
Publication of NO178620B publication Critical patent/NO178620B/no
Publication of NO178620C publication Critical patent/NO178620C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Lubricants (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO922686A 1991-07-09 1992-07-08 Isatinoksimderivater, farmasöytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for fremstilling av medikamenter NO178620C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72747991A 1991-07-09 1991-07-09

Publications (4)

Publication Number Publication Date
NO922686D0 NO922686D0 (no) 1992-07-08
NO922686L NO922686L (no) 1993-01-11
NO178620B NO178620B (no) 1996-01-22
NO178620C true NO178620C (no) 1996-05-02

Family

ID=24922831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922686A NO178620C (no) 1991-07-09 1992-07-08 Isatinoksimderivater, farmasöytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for fremstilling av medikamenter

Country Status (13)

Country Link
EP (1) EP0522494B1 (no)
JP (1) JP3270524B2 (no)
AT (1) ATE143659T1 (no)
AU (1) AU655643B2 (no)
CA (1) CA2073281A1 (no)
DE (1) DE69214205T2 (no)
DK (1) DK0522494T3 (no)
ES (1) ES2094850T3 (no)
FI (1) FI102276B (no)
GR (1) GR3021814T3 (no)
IE (1) IE921730A1 (no)
NO (1) NO178620C (no)
ZA (1) ZA924118B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
AR016384A1 (es) * 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
AU4910500A (en) 1999-05-19 2000-12-12 Neurosearch A/S Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69677B1 (en) * 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use
US5164404A (en) * 1991-03-15 1992-11-17 Neurosearch A/S Hydrazone derivatives and their use

Also Published As

Publication number Publication date
NO922686L (no) 1993-01-11
CA2073281A1 (en) 1993-01-10
JPH05201976A (ja) 1993-08-10
FI923032A0 (fi) 1992-06-30
DK0522494T3 (no) 1997-03-03
FI102276B1 (fi) 1998-11-13
ZA924118B (en) 1993-08-03
JP3270524B2 (ja) 2002-04-02
ES2094850T3 (es) 1997-02-01
AU655643B2 (en) 1995-01-05
FI923032A (fi) 1993-01-10
FI102276B (fi) 1998-11-13
NO178620B (no) 1996-01-22
DE69214205D1 (de) 1996-11-07
GR3021814T3 (en) 1997-02-28
NO922686D0 (no) 1992-07-08
IE921730A1 (en) 1993-01-13
AU1726892A (en) 1993-01-14
ATE143659T1 (de) 1996-10-15
EP0522494A1 (en) 1993-01-13
DE69214205T2 (de) 1997-02-06
EP0522494B1 (en) 1996-10-02

Similar Documents

Publication Publication Date Title
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
FI885594A (fi) Tiazolidindioner anvaendbara foer saenkande av blodsockerhalten samt atherosklerosis hindrande medel.
NO159017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater.
PT787489E (pt) Composicao contendo propionil-l-carnitina e acido hidroxicitrico ou acido pantotenico
ATE143598T1 (de) Arzneimittellösung enhaltend derivate von fk506
NO913136L (no) Fremgangsmaate for fremstilling av et preparat for oeyedraaper
IL84917A (en) Quinolinone derivative,its preparation and pharmaceutical compositions containing it
HUP0101112A2 (hu) Piperidinil-aminometil-trifluor-metil-ciklikus-éter típusú vegyületek substance P antagonistaként történő felhasználása és ezeket tartalmazó gyógyszerkészítmények
NO932520D0 (no) Preparat for helbredelse av sykdommen sjoegren's syndrom
MX9204914A (es) Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende.
NO178620C (no) Isatinoksimderivater, farmasöytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for fremstilling av medikamenter
DE69105786D1 (de) Harnstoffderivate, deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen.
ES2058085T3 (es) Composicion anticonvulsivante que contiene un derivado de aminoacido, y utilizacion de dicho derivado de aminoacido.
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
DE68909025D1 (de) Mittel zur Verhinderung von Zahnbelagbildung.
NO20020475L (no) 2-aminotetralinderivater for terapi av glaukom
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
ATE72433T1 (de) Aether und thioaether mit heilender wirkung, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DK165967C (da) Anvendelse af en 2-oxo-imidazolidinforbindelse til fremstilling af et farmaceutisk praeparat
DE3884878D1 (de) Uricosuretische Zusammensetzung.